Immune cells called NKT cells underly reduction in breast cancer associated with full-term pregnancy
As well as being the prelude to a baby-shaped bundle of giggles and screams, full-term pregnancy reduces the risk of breast cancer, for young mothers at least. Now, researchers are gaining clues as to how pregnancy boosts the breasts’ cancer-fighting capacity. Among the body’s anti-cancer defences are the patrolling immune cells, which destroy any rogue cancer cells that pop up. New work in mice shows that such immune cells – specifically, natural killer T (NKT) cells – become more abundant in mammary gland tissue after full-term pregnancy. It turns out post-pregnancy breast epithelial cells (coloured red) produce a protein called CD1d, which recruits NKT cells (green, arrowed). Without CD1d, fewer NKT cells migrated to the animals’ mammary glands and the cells were more prone to cancer-like growth. By understanding how NKT cell recruitment is boosted by pregnancy there’s hope the process could be induced clinically in cancer patients to support treatment.
BPoD stands for Biomedical Picture of the Day. Managed by the MRC London Institute of Medical Sciences the website aims to engage everyone, young and old, in the wonders of biomedicine. Images are kindly provided for inclusion on this website through the generosity of scientists across the globe.
BPoD is also available in Catalan at www.bpod.cat with translations by the University of Valencia.